Stock fact sheet · data as of

Medtronic Plc (MDT): fair value, margin of safety and Wheel Score

Healthcare · Medical - Devices · Ireland · Defensive

Close95.45
GLS fair value76.379 of 9 models
Margin of safety-25%price above fair value
Wheel Score64Fairout of 100
Health9/9Piotroski F-score
Moat5.3/10GLS 10-year score
Market cap$122.1B50.2M shares a day
Implied vol.29%near-the-money, 20-60 d
P/E23.4EPS 4.09
Dividend yield3.00%payout 70%
Beta0.57moves less than the market
Next earnings17 Nov 2026in 32 days (before the open)

Is MDT undervalued?

At 95.45 (close of 16 Oct 2026), MDT trades 25% over the GLS average fair value of 76.37. 4 of the 9 models land above the price and 5 below. A negative margin of safety costs Value points in the Wheel Score (2 of 25 here) - the models see no discount, which does not make the business a poor one, only the price a full one.

There is a wide gap between GLS Growth (27.92) and DCF (152.30). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.

The nightly engine files MDT under Defensive: a low beta, a dividend and positive earnings.

Nine valuation models for MDT

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF152.30+60%Present value of the projected free cash flows, discounted at the cost of capital
Graham Number60.07-37%The most a defensive investor pays for the earnings and book value per share
Graham Growth96.76+1%Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields
Lynch32.11-66%EPS × the earnings growth rate (PEG of 1), growth capped at 25%
GLS Growth27.92-71%EPS compounded ten years at the blended growth rate, discounted back at 15% a year
10 Cap125.42+31%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time105.27+10%Eight years of compounded free cash flow: the price at which the business pays for itself
DDM42.08-56%Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend
EPV45.41-52%Earnings power value: current EPS capitalised at 9% with no growth
Zombie (liquidation)-14.20-115%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target97.73+2%Analysts' average 12-month price target. Not in the average

Quality and financial health

Medtronic Plc scores 9 of 9 on the Piotroski F-score, the nine yes/no tests of profitability, leverage and efficiency on the latest annual accounts - a strong reading that passes the Sunday Scan's "6 or more" rule with room to spare. On durability MDT scores 5.3/10 on the GLS Moat - a middle reading; the Scorecard on the Quote page's Financials tab shows which ten-year lines are steady and which are not.

Returns on capital are moderate - ROIC 6.2%, ROE 9.7%, ROA 5.2% - with debt at 0.57 times equity and a free-cash-flow yield of 5.0%.

The dividend yield is 3.00% at a payout ratio of 70%; for a wheel trader holding assigned shares the dividend adds to the covered-call premium, and the ex-dividend date is worth knowing before a call is sold. Revenue comes mainly from Cardiac and Vascular Group 40%, Neuroscience Group 28%, Medical Surgical 23% (quarter Q1 FY2027).

Institutional ownership scores 10/10, insider activity 4/10 and Congressional trading 2/10 on the GLS smart-money scales.

Piotroski F-score9 / 9ROIC6.2%
GLS Moat5.3 / 10ROE9.7%
Debt / equity0.57ROA5.2%
Free-cash-flow yield5.0%Payout ratio70%
Institutions10 / 10Insiders · Congress4 · 2 / 10

Wheel Score 64: Fair

A Wheel Score of 64 puts Medtronic Plc in the Fair band - below the 70 the Sunday Scan requires. Value 2/25, Health 20/20, Moat 8/15, Premium 14/20 and Stability 20/20; the weakest part is Value (2/25).

Implied volatility is 29% on the near-the-money contracts 20-60 days out: some premium, but under the 35-60% range the Wheel Score pays full marks for (14 of 20 points). The option chain is deep: 339,317 contracts of open interest across all expiries, which means tight fills at most strikes.

Volume runs at 50.2M shares a day on a market cap of $122.1B, with a beta of 0.57 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 20 of 20.

PartPointsFrom
Value2 / 25-25% margin of safety
Health20 / 20Piotroski 9/9
Moat8 / 15moat 5.3/10
Premium14 / 20implied volatility 29%
Stability20 / 2050.2M shares/day, $122.1B cap, beta 0.57

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

The next earnings report is due on 17 Nov 2026 (before the open), 32 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Medical - Devices

The 12 companies below are the closest to Medtronic Plc by market cap within the Medical - Devices industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
SYK
Stryker Corporation
281.63211.44-33%68Good$108.0B
ABT
Abbott Laboratories
104.6967.26-56%62Fair$181.2B
BSX
Boston Scientific Corporation
44.1465.77+33%95Prime$64.0B
EW
Edwards Lifesciences Corporation
88.1039.75-122%62Fair$50.8B
DXCM
DexCom, Inc.
87.7180.03-10%78Good$33.1B
GEHC
GE HealthCare Technologies Inc.
70.3551.87-36%58Fair$31.8B
PHG
Koninklijke Philips N.V.
25.0037.85+34%82Prime$24.2B
ZBH
Zimmer Biomet Holdings, Inc.
91.77134.51+32%87Prime$17.5B
PEN
Penumbra, Inc.
320.12139.38-130%54Fair$12.6B
SNN
Smith & Nephew plc
27.8837.94+27%90Prime$11.7B
ALGN
Align Technology, Inc.
149.34125.50-19%66Good$10.6B
GMED
Globus Medical, Inc.
78.84112.94+30%92Prime$10.6B

⚖ Compare MDT with 7 of them   All Healthcare stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about MDT

Is MDT undervalued right now?

No: at 95.45 the stock trades 25% above the GLS average fair value of 76.37 (data as of 16 Oct 2026). The margin of safety is negative.

What is the Wheel Score of MDT and what does it mean?

MDT scores 64 out of 100 (Fair). The Wheel Score blends the margin of safety (25 points), Piotroski health (20), the GLS moat (15), the option premium on offer (20) and trading stability (20) into one number that ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned. 80 and above is Prime, 65-79 Good, 50-64 Fair, under 50 Weak.

What is the GLS fair value for MDT?

76.37 per share as of 16 Oct 2026 - the simple average of the 9 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does Medtronic Plc report earnings next?

The next earnings report is due on 17 Nov 2026 (before the open), 32 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.

Does MDT have listed options, and how liquid are they?

Yes. The nightly snapshot found 1,000 listed contracts with 339,317 open interest across all expiries and implied volatility of 29% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.